Atlas Trials

Selumetinib in Combination With Gefitinib in NSCLC Patients

Clinical trial NCT02025114 · COMPLETED

Trial details

NCT number
NCT02025114
Sponsor
National Taiwan University Hospital
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer (NSCLC)
Start date
2014-09-01
Primary completion
2018-03-08
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.